Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass

被引:35
作者
Pepper, JR
Mumby, S
Gutteridge, JMC
机构
[1] ROYAL BROMPTON HOSP, DEPT ANAESTHESIA & INTENS CARE, NATL HEART & LUNG INST, CRIT CARE UNIT, LONDON SW3 6NP, ENGLAND
[2] ROYAL BROMPTON HOSP, DEPT CARDIOTHORAC SURG, NATL HEART & LUNG INST, LONDON SW3 6NP, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1016/0003-4975(95)00896-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Cardiopulmonary bypass and;crossclamping of the ascending aorta introduce two well-characterized phases of oxidative stress, namely, the extracorporeal circulation of blood and the reoxygenation of ischemic tissue. A feature of both forms of stress is the release of reactive and damaging oxygen species. Methods. Forty-seven patients undergoing aortic valve replacement received either cold crystalloid, cold blood, or warm blood cardioplegia. Plasma thiol levels were measured in all groups before and during bypass. All cardiopulmonary bypass patients had, before going onto bypass, low plasma thiol levels (3.80 +/- 0.22 nmol/mg protein) compared with normal healthy controls (5.48 +/- 0.14 nmol/mg protein). Results. Thiol values remained low throughout bypass in patients receiving cold crystalloid cardioplegia, but rose in patients receiving cold blood cardioplegia, and rose even more in patients receiving warm blood cardioplegia to reach normal plasma values. During cardiopulmonary bypass it has previously been reported that plasma transferrin can become fully saturated with iron and cause transient iron overload. Two patients (13%) receiving cold crystalloid cardioplegia went into plasma iron overload, whereas 18% receiving cold blood and 27% receiving warm blood cardioplegia showed plasma iron overload. Conclusions. We suggest that blood cardioplegia provides an additional source of thiols as well as a source of reactive iron. However, the reactive iron and thiol-containing molecules have the potential to interact and exacerbate oxidative stress, already a feature of bypass. Control of reactive iron by chelation may be strongly indicated when blood cardioplegia is used.
引用
收藏
页码:1735 / 1740
页数:6
相关论文
共 19 条
[11]  
Meister, On the antioxidant effects of ascorbic acid and glutathione, Biochem Pharmacol, 44, pp. 1905-1915, (1992)
[12]  
Tien, Bucher, Aust, Thiol-dependent lipid peroxidation, Biochem Biophys Res Commun, 107, pp. 279-285, (1982)
[13]  
Gutteridge, Reduction of low molecular mass iron by reduction molecules present in plasma and the protective action of caeruloplasmin, J Trace Elem Electrolytes Health Dis, 5, pp. 279-281, (1991)
[14]  
Darley-Usmar, O'Leary, Stone, The glutathione status of perfused rat hearts subjected to hypoxia and reoxygenation: the oxygen paradox, Free Radic Res Commun, 5, pp. 283-289, (1989)
[15]  
Lesnefsky, Repine, Horwitz, Oxidation and release of glutathione from myocardium during early reperfusion, Free Radic Biol Med, 7, pp. 31-35, (1989)
[16]  
Julia, Buckberg, Acar, Et al., Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage—importance of endogenous oxygen free radical scavengers in red blood cells, J Thorac Cardiovasc Surg, 101, pp. 303-313, (1991)
[17]  
Bical, Gerhardt, Paumier, Et al., Comparison of different types of cardioplegia and reperfusion on myocardial metabolism and free radical activity, Circulation, 84, pp. 375-379, (1991)
[18]  
Quinlan, Mumby, Pepper, Gutteridge, Plasma 4-hydroxy-2-nonenal levels during cardiopulmonary bypass, and their relationship to the iron-binding of transferrin, Biochem Mol Biol Int, 34, pp. 1277-1282, (1994)
[19]  
Menasche, Antebi, Alcindor, Et al., Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans, Circulation, 82, pp. 390-396, (1990)